Sign in Subscribe
Cancer research

Etoposide Induces Protein Kinase Cdelta- and Caspase-3-Dependent Apoptosis in Neuroblastoma Cancer Cells

Strategic Insights

— 1 min read

Scientists in the United States have published a study revealing that etoposide inhibits the proliferation of SK-N-AS neuroblastoma cancer cells and promotes protein kinase Cdelta (PKCdelta)- and caspase-dependent apoptosis. The study found that etoposide induces the caspase-3-dependent cleavage of PKCdelta to its active p40 fragment, leading to a positive-feedback mechanism that triggers the processing of caspase-3. This research provides important insights into how etoposide mediates apoptotic signaling and may lead to the development of novel therapeutics for neuroblastoma treatment.

Key Takeaways:

  • Etoposide inhibits the proliferation of SK-N-AS neuroblastoma cancer cells and promotes protein kinase Cdelta (PKCdelta)- and caspase-dependent apoptosis.
  • Etoposide induces the caspase-3-dependent cleavage of PKCdelta to its active p40 fragment, leading to a positive-feedback mechanism that triggers the processing of caspase-3.
  • Treatment with a caspase-3-specific inhibitor or caspase-3-specific small interfering RNA (siRNA) prevented etoposide-induced apoptosis.
  • Silencing of the caspase-2 or caspase-8 genes using siRNAs did not affect etoposide-induced processing of caspase-3, indicating that these caspases lie downstream of caspase-3 in the signaling pathway.
  • Etoposide-mediated apoptosis was decreased by treating cells with a caspase-6-specific inhibitor, indicating that caspase-6 is activated by a caspase-8-dependent mechanism.
  • Rottlerin blocked etoposide-induced apoptosis by inhibiting PKCdelta-mediated activation of caspase-3 and degrading caspase-2, which prevents caspase-8 activation.
  • The study concludes that targeting these pathways may lead to the development of novel therapeutics for neuroblastoma treatment.

Statistics:

  • The study used SK-N-AS neuroblastoma cancer cells as the model system for the experiments.
  • The caspase-3-specific inhibitor used in the study was N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone.
  • The caspase-6-specific inhibitor used in the study was benzyloxycarbonyl-Val-Glu(OMe)-Ile-Asp-(OMe)-fluoromethyl ketone.
  • The siRNA used in the study was caspase-3-specific siRNA.

Sources:

  • Day, T.W., et al. "Etoposide induces protein kinase Cdelta- and caspase-3-dependent apoptosis in neuroblastoma cancer cells." Molecular Pharmacology, vol. 76, no. 3, 2009, pp. 632-40.
  • "Cysteine Endopeptidases." Biotech Week, 2010.
  • "Apoptosis Regulatory Proteins, Cancer, Caspase 3, Caspase 8, Cysteine Endopeptidases, Cysteine Proteases, Effector Caspases, Enzymes and Coenzymes, Hematology, Initiator Caspases, Neuroblastoma, Oncology, Peptide Hydrolases, Peptides, Phosphotransferases (Alcohol Group Acceptor), Protein Kinase C, Protein Kinases, Proteomics, Transferases." Keywords, Biotech Week, 2010.

Read more